Skip to main content

Licart Dosage

Generic name: DICLOFENAC EPOLAMINE 0.013g
Dosage form: topical system
Drug class: Topical non-steroidal anti-inflammatories

Medically reviewed by Last updated on Dec 1, 2023.

Important Dosage and Administration Information

Use the lowest effective dosage for the shortest duration consistent with individual patient treatment goals [see Warnings and Precautions (5)] .

LICART is intended for topical use only.

Convey the following important administration instructions to the patient:

  • If LICART begins to peel-off, the edges of the topical system may be taped down. If problems with adhesion persist, patients may overlay the topical system with a mesh netting sleeve, where appropriate (e.g., to secure topical systems applied to ankles, knees, or elbows). The mesh netting sleeve (e.g., Curad® Hold Tite™, Surgilast® Tubular Elastic Dressing) must allow air to pass through and not be occlusive (i.e., non-breathable) 1.
  • Do not apply LICART to non-intact or damaged skin resulting from any etiology, e.g., exudative dermatitis, eczema, infected lesion, burns or wounds.
  • Do not wear a LICART topical system when bathing or showering.
  • Wash your hands after applying, handling, or removing the topical system.
  • Avoid contact with eyes.
  • Do not use LICART in combination with an oral NSAID unless the benefit outweighs the risk and periodic laboratory evaluations are conducted.

Curad ® Hold Tite™ is a trademark of Medline Industries, Inc., and Surgilast ® Tubular Elastic Dressing is a trademark of Derma Sciences, Inc.

Recommended Dose

The recommended dose is one (1) LICART topical system to the most painful area once daily.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.